Unknown

Dataset Information

0

Tricyclic 2'-C-modified nucleosides as potential anti-HCV therapeutics.


ABSTRACT: Promising biological activity in a number of therapeutic areas has been reported for both tricyclic nucleosides and 2'-modified nucleosides. In particular, disubstitution at the C-2' position of nucleosides has resulted in significant activity against the hepatitis C virus (HCV). Combining this with the observation that tricyclic nucleosides developed in our laboratory have been shown to inhibit the RNA-dependent RNA polymerase NS5B led to the design of a series of 2'-modified tricyclic nucleosides. Details of the synthesis, structural characterization, and preliminary biological results are reported.

SUBMITTER: Wauchope OR 

PROVIDER: S-EPMC2975515 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tricyclic 2'-C-modified nucleosides as potential anti-HCV therapeutics.

Wauchope Orrette R OR   Tomney Matthew J MJ   Pepper Joseph L JL   Korba Brent E BE   Seley-Radtke Katherine L KL  

Organic letters 20101001 20


Promising biological activity in a number of therapeutic areas has been reported for both tricyclic nucleosides and 2'-modified nucleosides. In particular, disubstitution at the C-2' position of nucleosides has resulted in significant activity against the hepatitis C virus (HCV). Combining this with the observation that tricyclic nucleosides developed in our laboratory have been shown to inhibit the RNA-dependent RNA polymerase NS5B led to the design of a series of 2'-modified tricyclic nucleosi  ...[more]

Similar Datasets

| S-EPMC4060939 | biostudies-literature
| S-EPMC4562313 | biostudies-literature
| S-EPMC9737395 | biostudies-literature
| S-EPMC3172287 | biostudies-literature
| S-EPMC8279913 | biostudies-literature
2019-06-20 | GSE126405 | GEO
| S-EPMC8293910 | biostudies-literature
| S-EPMC8224626 | biostudies-literature
| S-EPMC3799853 | biostudies-literature
| S-EPMC5693771 | biostudies-literature